News Sentiment

ZLNA sentiment intelligence

Zelluna ASA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 11 relevant articles
Exchange OSL Norway
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 19.40 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

95/100 classification confidence.

Company focus 11

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+0.0% over one week, -5.4% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Zelluna doses first solid tumour patient with ZI-MA4-1 in the ZIMA-101 Phase 1 trial

Market Reaction

Balanced read

53/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 95/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend active -5.4% over four weeks
Fair value -92.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 11
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 11
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
GlobeNewswire 3
Market source 3
Finansavisen 2
The Manila Times 2
TradingView 1

Event Lens

What the news is about

Classified themes
Market update 11

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-11 of 11